SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Cardiorespiratory Response to Exercise in Parkinson's Disease: Associations with Autonomic Dysfunction and Physical Activity.

Mov Disord Clin Pract · 2025-06-09

DOI: 10.1002/mdc3.70172PMID: 40485648

Open accessResearch Support, Non-U.S. Gov't; research-article; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

BackgroundBoth autonomic dysfunction and low levels of physical activity could contribute to reduced cardiorespiratory fitness in people with Parkinson's disease (PD). However, the interrelationship between these concepts is not well understood.ObjectivesOur aim was to gain more insight into autonomic dysfunction and physical activity in relation to cardiorespiratory fitness in PD.MethodsWe included 59 individuals with PD (37% women, mean age 65.1 years; mean disease duration 4.5 years; Hoehn and Yahr stage 1-3). All participants completed a cardiopulmonary exercise test (CPET). We examined the association between parameters assessed during a CPET (peak oxygen consumption [VO2peak], maximum heart rate [HRmax], heart rate recovery at 1 and 3 mins [HRrec1, HRrec3]), autonomic dysfunction (Scales for Outcomes in Parkinson's disease-Autonomic dysfunction, SCOPA-AUT), and physical activity in daily life (step counts, measured using a smartphone for a period of 4 weeks). Using multivariable regression, we adjusted for age, sex, and beta blocker use.ResultsHigher SCOPA-AUT was associated with lower HRmax (β = -0.72, 95% CI = [-1.40, -0.04], P = 0.040). Higher step counts were associated with higher HRrec3 (β = 3.21, 95% CI = [0.56, 5.86], P = 0.019), and with higher VO2peak (β = 1.16, 95% CI = [0.10, 2.22], P = 0.032). No statistically significant associations were found between both SCOPA-AUT and step counts with HRrec1.ConclusionsBoth autonomic dysfunction and physical activity are associated with a reduced cardiorespiratory response to exercise in PD, but affected different CPET parameters. Future studies should determine the responsiveness of these CPET parameters to change, in order to implement such parameters as endpoints in clinical trials.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.